We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Faster Ambulance Response Could Cut Deaths

By HospiMedica staff writers
Posted on 11 Jul 2001
A study has found that the survival rate of patients in cardiac arrest could be almost doubled if ambulances reduced their response time to five minutes. More...
The study, conducted by a team of researchers at the University of Glasgow (Scotland), was reported in the June 9, 2001, issue of the British Medical Journal.

The team analyzed all out-of-hospital cases of cardiopulmonary arrest due to heart disease that were attended by the Scottish Ambulance Service between May 1991 and March 1998. This was to determine the association between ambulance response and cardiac arrest survival. Using this information, the team developed two predictive models that could be used to assess the effect of reduced responses on survival.

The response time of ambulances was found to be independently associated with defibrillation and survival. Ambulances in the United Kingdom are currently required to respond to 90% of emergency calls within 14 minutes. The research team's predictive models showed that lowering this time to eight minutes would have the effect of increasing survival from 6-8%. Lowering the response time to within five minutes would increase survival 10-11%.

However, as the authors noted, reducing response time would require additional resources. Another solution is suggested by previous studies, which found that equipping other first line responders, such as fire fighters and the police, with defibrillators to reduce response time would also help to reduce the additional cost.




Related Links:
British Medical Journal

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.